Finance

Lists
Why is NWBO up 6.08%?
Dive Deeper
NWBO:OTCMKTS
Northwest Biotherapeutics Inc
$ 0.16
+6.08%
(+0.0090) 1D
10-р сарын 9, 16:00:00 (GMT-4)  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NWBO...
Open
$ 0.16
High
$ 0.16
Low
$ 0.15
Mkt. cap
267.79 сая
Avg. vol.
3.46 сая
Volume
0.00
52-wk high
$ 0.34
52-wk low
$ 0.14
EPS
-$ 0.03
Beta
-0.62
Shares outstanding
1.71 тэрбум
No. of employees
105
Open
$ 0.16
High
$ 0.16
Low
$ 0.15
Mkt. cap
267.79 сая
Avg. vol.
3.46 сая
Volume
0.00
52-wk high
$ 0.34
52-wk low
$ 0.14
EPS
-$ 0.03
Beta
-0.62
Shares outstanding
1.71 тэрбум
No. of employees
105
News stories
From web sources and news partners
Profile
Northwest Biotherapeutics, Inc. is a development-stage American pharmaceutical company headquartered in Maryland that focuses on developing immunotherapies against different types of cancer. It was founded in 1996 by Alton L. Boynton. Wikipedia
About Northwest Biotherapeutics Inc
CEO-
Employees105
Founded1998 оны 1-р сарын 1
Headquarters-
Sector-
Websitenwbio.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
200.00 мян
672.00 мян
494.00 мян
807.00 мян
Cost of goods sold
7.45 сая
5.55 сая
4.86 сая
5.70 сая
Cost of revenue
7.45 сая
5.55 сая
4.86 сая
5.70 сая
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7.07 сая
8.62 сая
6.54 сая
6.71 сая
Operating expense
7.07 сая
8.62 сая
6.54 сая
6.71 сая
Total operating expenses
14.52 сая
14.18 сая
11.39 сая
12.41 сая
Operating income
-14.32 сая
-13.50 сая
-10.90 сая
-11.60 сая
Other non operating income
-3.45 сая
1.14 сая
9.53 сая
64.00 мян
EBT including unusual items
-26.83 сая
851.00 мян
-3.07 сая
-9.22 сая
EBT excluding unusual items
-21.20 сая
-14.82 сая
-5.06 сая
-13.47 сая
Income tax expense
-
-537.00 мян
-
-
Effective tax rate
-
-63.10%
-
-
Other operating expenses
-
-
-
-
Net income
-26.83 сая
1.39 сая
-3.07 сая
-9.22 сая
Net profit margin
-13,414.50%
206.55%
-621.25%
-1,142.63%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-2.62 сая
-2.65 сая
-2.35 сая
-1.81 сая
Net interest expenses
-2.62 сая
-2.65 сая
-2.35 сая
-1.81 сая
Depreciation and amortization charges
-
-
-
-
EBITDA
-13.87 сая
-12.78 сая
-10.13 сая
-10.83 сая
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google аппс